drug_id,canonical_name,chembl_pref_name,max_mechanism_score,max_mechanism_score_global,top_disease,final_score,endpoint_type,n_trials,trial_statuses,trial_source,example_condition,why_stopped,ci_lower,ci_upper,ci_width,confidence_tier,n_evidence_paths,source
D6426120808,emricasan,EMRICASAN,1.1519,11.4049,atherosclerosis,1.3115,OTHER,,,,,,0.114681,0.115942,0.00126,HIGH,10,kg
D7412DBCFC8,digitoxin,DIGITOXIN,1.0183,1.9544,coronary atherosclerosis,1.2154,OTHER,,,,,,0.102585,0.254577,0.151991,MEDIUM,5,kg
D6E2DD7C465,lanatoside c,LANATOSIDE C,1.0183,1.9544,coronary atherosclerosis,1.2154,OTHER,,,,,,0.102585,0.254577,0.151991,MEDIUM,5,kg
D90C80F55F8,istaroxime,ISTAROXIME,1.0183,1.9544,coronary atherosclerosis,1.2154,OTHER,,,,,,0.102585,0.254577,0.151991,MEDIUM,5,kg
D7E2185FACB,acetyldigitoxin,ACETYLDIGITOXIN,1.0183,1.9544,coronary atherosclerosis,1.2154,OTHER,,,,,,0.102585,0.254577,0.151991,MEDIUM,5,kg
DD447FC3E7E,digoxin,DIGOXIN,1.0183,1.9544,coronary atherosclerosis,0.9479,OTHER,,,,,,0.102585,0.254577,0.151991,MEDIUM,5,kg
D4CFE22B7E9,deslanoside,DESLANOSIDE,1.0183,1.9544,coronary atherosclerosis,1.2154,OTHER,,,,,,0.102585,0.254577,0.151991,MEDIUM,5,kg
DA1F49289FB,belnacasan,BELNACASAN,0.7251,7.1957,atherosclerosis,0.8152,OTHER,,,,,,0.072197,0.072992,0.000795,HIGH,10,kg
D27AF93BF3E,nivocasan,NIVOCASAN,0.7251,7.1957,atherosclerosis,0.8152,OTHER,,,,,,0.072197,0.072992,0.000795,HIGH,10,kg
DB449FF5655,ritlecitinib tosylate,RITLECITINIB TOSYLATE,0.6503,9.142,coronary atherosclerosis,0.7404,OTHER,,,,,,0.006731,0.147349,0.140618,MEDIUM,12,kg
D27314D499C,ritlecitinib,RITLECITINIB,0.6503,9.142,coronary atherosclerosis,0.6496,OTHER,,,,,,0.006731,0.147349,0.140618,MEDIUM,12,kg
DFAD8C5AACF,brensocatib,BRENSOCATIB,0.3307,5.3343,atherosclerosis,0.3386,OTHER,,,,,,0.082663,0.082663,0.0,HIGH,4,kg
D33E5CC3C5E,tofacitinib citrate,TOFACITINIB CITRATE,0.2546,5.3075,coronary atherosclerosis,0.3002,OTHER,,,,,,0.001258,0.16115,0.159892,MEDIUM,5,kg
DA13F2E6357,izencitinib,IZENCITINIB,0.2546,5.3075,coronary atherosclerosis,0.3002,OTHER,,,,,,0.001258,0.16115,0.159892,MEDIUM,5,kg
DDD31DCE9F0,peficitinib,PEFICITINIB,0.2546,5.3075,coronary atherosclerosis,0.3002,OTHER,,,,,,0.001258,0.16115,0.159892,MEDIUM,5,kg
DDFAB976C9E,gusacitinib,GUSACITINIB,0.2546,5.3075,coronary atherosclerosis,0.3002,OTHER,,,,,,0.001258,0.16115,0.159892,MEDIUM,5,kg
DFA7535532F,delgocitinib,DELGOCITINIB,0.2546,5.3075,coronary atherosclerosis,0.2795,OTHER,,,,,,0.001258,0.16115,0.159892,MEDIUM,5,kg
D4754F12AB5,nezulcitinib,NEZULCITINIB,0.2546,5.3075,coronary atherosclerosis,0.3002,OTHER,,,,,,0.001258,0.16115,0.159892,MEDIUM,5,kg
D634667DE08,jnj-54175446,JNJ-54175446,0.2142,1.1972,atherosclerosis,0.2408,OTHER,,,,,,0.032411,0.053262,0.020851,HIGH,5,kg
DE6C23789D8,azd9056,AZD9056,0.2142,1.1972,atherosclerosis,0.2408,OTHER,,,,,,0.032411,0.053262,0.020851,HIGH,5,kg
D35F581EA32,ce-224535,CE-224535,0.2142,1.1972,atherosclerosis,0.2408,OTHER,,,,,,0.032411,0.053262,0.020851,HIGH,5,kg
D5C53B40824,peginterferon alfa-2a,PEGINTERFERON ALFA-2A,0.1994,2.1109,coronary atherosclerosis,0.1823,OTHER,,,,,,0.000985,0.199357,0.198372,MEDIUM,2,kg
D890AE26B3C,filgotinib,FILGOTINIB,0.1994,4.0373,coronary atherosclerosis,0.2314,OTHER,,,,,,0.000985,0.199357,0.198372,MEDIUM,2,kg
DDE9F1310A6,filgotinib maleate,FILGOTINIB MALEATE,0.1994,4.0373,coronary atherosclerosis,0.2314,OTHER,,,,,,0.000985,0.199357,0.198372,MEDIUM,2,kg
DCE8B22B283,interferon alfa-n3,INTERFERON ALFA-N3,0.1994,2.1109,coronary atherosclerosis,0.2351,OTHER,,,,,,0.000985,0.199357,0.198372,MEDIUM,2,kg
DCB5D842E24,interferon alfa-2a,INTERFERON ALFA-2A,0.1994,2.1109,coronary atherosclerosis,0.2351,OTHER,,,,,,0.000985,0.199357,0.198372,MEDIUM,2,kg
D47084BDD12,interferon alfa-2b,INTERFERON ALFA-2B,0.1994,2.1109,coronary atherosclerosis,0.2351,OTHER,,,,,,0.000985,0.199357,0.198372,MEDIUM,2,kg
D78965647F7,peginterferon beta-1a,PEGINTERFERON BETA-1A,0.1994,2.1109,coronary atherosclerosis,0.193,OTHER,,,,,,0.000985,0.199357,0.198372,MEDIUM,2,kg
DD10E9B48FF,interferon beta-1a,INTERFERON BETA-1A,0.1994,2.1109,coronary atherosclerosis,0.1785,OTHER,,,,,,0.000985,0.199357,0.198372,MEDIUM,2,kg
D1C7453FAE3,interferon beta-1b,INTERFERON BETA-1B,0.1994,2.1109,coronary atherosclerosis,0.1909,OTHER,,,,,,0.000985,0.199357,0.198372,MEDIUM,2,kg
DF0FF5319EF,peginterferon alfa-2b,PEGINTERFERON ALFA-2B,0.1994,2.1109,coronary atherosclerosis,0.2351,OTHER,,,,,,0.000985,0.199357,0.198372,MEDIUM,2,kg
DA5CD2798AC,interferon alfacon-1,INTERFERON ALFACON-1,0.1994,2.1109,coronary atherosclerosis,0.2351,OTHER,,,,,,0.000985,0.199357,0.198372,MEDIUM,2,kg
D0940815536,cerdulatinib,CERDULATINIB,0.1994,4.0373,coronary atherosclerosis,0.2314,OTHER,,,,,,0.000985,0.199357,0.198372,MEDIUM,2,kg
D9DF2ECAB8B,r-333,R-333,0.1994,4.0373,coronary atherosclerosis,0.2314,OTHER,,,,,,0.000985,0.199357,0.198372,MEDIUM,2,kg
D2CB9A9FD13,r-348,R-348,0.1994,4.0373,coronary atherosclerosis,0.2314,OTHER,,,,,,0.000985,0.199357,0.198372,MEDIUM,2,kg
D9575C0DC4A,upadacitinib hemihydrate,UPADACITINIB HEMIHYDRATE,0.1994,4.0373,coronary atherosclerosis,0.2314,OTHER,,,,,,0.000985,0.199357,0.198372,MEDIUM,2,kg
DEF424D1E56,deuruxolitinib phosphate,DEURUXOLITINIB PHOSPHATE,0.1994,4.0373,coronary atherosclerosis,0.2314,OTHER,,,,,,0.000985,0.199357,0.198372,MEDIUM,2,kg
DEE50934758,decernotinib,DECERNOTINIB,0.1994,4.0373,coronary atherosclerosis,0.2314,OTHER,,,,,,0.000985,0.199357,0.198372,MEDIUM,2,kg
DDDB73C41D9,albinterferon alfa-2b,ALBINTERFERON ALFA-2B,0.1994,2.1109,coronary atherosclerosis,0.2351,OTHER,,,,,,0.000985,0.199357,0.198372,MEDIUM,2,kg
DD26EE55A12,ropeginterferon alfa-2b,ROPEGINTERFERON ALFA-2B,0.1994,2.1109,coronary atherosclerosis,0.203,OTHER,,,,,,0.000985,0.199357,0.198372,MEDIUM,2,kg
D48BA08022D,at-9283,AT-9283,0.1994,4.0373,coronary atherosclerosis,0.2314,OTHER,,,,,,0.000985,0.199357,0.198372,MEDIUM,2,kg
D4671FAB5F8,tirabrutinib,TIRABRUTINIB,0.1627,3.2629,coronary atherosclerosis,0.1627,OTHER,,,,,,0.000804,0.045881,0.045077,HIGH,11,kg
DE65C3E4092,orelabrutinib,ORELABRUTINIB,0.1627,3.2629,coronary atherosclerosis,0.1627,OTHER,,,,,,0.000804,0.045881,0.045077,HIGH,11,kg
D330252C985,zanubrutinib,ZANUBRUTINIB,0.1627,3.2629,coronary atherosclerosis,0.1385,OTHER,,,,,,0.000804,0.045881,0.045077,HIGH,11,kg
D03870D3F01,pirtobrutinib,PIRTOBRUTINIB,0.1627,3.2629,coronary atherosclerosis,0.1441,OTHER,,,,,,0.000804,0.045881,0.045077,HIGH,11,kg
D7E49BEA50B,vecabrutinib,VECABRUTINIB,0.1627,3.2629,coronary atherosclerosis,0.1627,OTHER,,,,,,0.000804,0.045881,0.045077,HIGH,11,kg
D7D1F3D59B3,spebrutinib besylate,SPEBRUTINIB BESYLATE,0.1627,3.2629,coronary atherosclerosis,0.1627,OTHER,,,,,,0.000804,0.045881,0.045077,HIGH,11,kg
DF6543DEB42,rilzabrutinib,RILZABRUTINIB,0.1627,3.2629,coronary atherosclerosis,0.1509,OTHER,,,,,,0.000804,0.045881,0.045077,HIGH,11,kg
D6E85BA48F6,tolebrutinib,TOLEBRUTINIB,0.1627,3.2629,coronary atherosclerosis,0.1627,OTHER,,,,,,0.000804,0.045881,0.045077,HIGH,11,kg
DE3C6FB46F6,poseltinib,POSELTINIB,0.1627,3.2629,coronary atherosclerosis,0.1627,OTHER,,,,,,0.000804,0.045881,0.045077,HIGH,11,kg
DF2A6981049,abivertinib,ABIVERTINIB,0.1627,3.2629,coronary atherosclerosis,0.1627,OTHER,,,,,,0.000804,0.045881,0.045077,HIGH,11,kg
DA084E0A238,acalabrutinib maleate,ACALABRUTINIB MALEATE,0.1627,3.2629,coronary atherosclerosis,0.1627,OTHER,,,,,,0.000804,0.045881,0.045077,HIGH,11,kg
DA7F157C15E,branebrutinib,BRANEBRUTINIB,0.1627,3.2629,coronary atherosclerosis,0.1627,OTHER,,,,,,0.000804,0.045881,0.045077,HIGH,11,kg
DA7B9CF5A43,abivertinib maleate,ABIVERTINIB MALEATE,0.1627,3.2629,coronary atherosclerosis,0.1627,OTHER,,,,,,0.000804,0.045881,0.045077,HIGH,11,kg
D6A99A26F93,ibrutinib,IBRUTINIB,0.1627,3.2629,coronary atherosclerosis,0.1237,OTHER,,,,,,0.000804,0.045881,0.045077,HIGH,11,kg
D36924DC9FA,fenebrutinib,FENEBRUTINIB,0.1627,3.2629,coronary atherosclerosis,0.1627,OTHER,,,,,,0.000804,0.045881,0.045077,HIGH,11,kg
DFAF3DAD610,evobrutinib,EVOBRUTINIB,0.1627,3.2629,coronary atherosclerosis,0.1627,OTHER,,,,,,0.000804,0.045881,0.045077,HIGH,11,kg
DC8007EC40F,elsubrutinib,ELSUBRUTINIB,0.1627,3.2629,coronary atherosclerosis,0.1627,OTHER,,,,,,0.000804,0.045881,0.045077,HIGH,11,kg
DE27D683B70,bms-986142,BMS-986142,0.1627,3.2629,coronary atherosclerosis,0.1627,OTHER,,,,,,0.000804,0.045881,0.045077,HIGH,11,kg
DAD8706A9C8,edralbrutinib,EDRALBRUTINIB,0.1627,3.2629,coronary atherosclerosis,0.1627,OTHER,,,,,,0.000804,0.045881,0.045077,HIGH,11,kg
DCC5BB68E81,acalabrutinib,ACALABRUTINIB,0.1627,3.2629,coronary atherosclerosis,0.1326,OTHER,,,,,,0.000804,0.045881,0.045077,HIGH,11,kg
D56A81CE29E,bms-986020,BMS-986020,0.1358,1.8506,atherosclerosis,0.1433,OTHER,,,,,,0.044447,0.046895,0.002449,HIGH,3,kg
D51D3A17774,rovelizumab,ROVELIZUMAB,0.124,10.3324,atherosclerosis,0.1462,OTHER,,,,,,0.041331,0.082663,0.041331,HIGH,2,kg
D3ECDFB446E,odulimomab,ODULIMOMAB,0.0827,6.4578,atherosclerosis,0.0975,OTHER,,,,,,0.08266264534481291,0.08266264534481291,0.0,HIGH,1,kg
D68B2063BD0,mlnm-2201,MLNM-2201,0.0522,4.8893,atherosclerosis,0.0615,OTHER,,,,,,0.052154322456967585,0.052154322456967585,0.0,HIGH,1,kg
D123F7E2169,erlizumab,ERLIZUMAB,0.0522,4.8893,atherosclerosis,0.0615,OTHER,,,,,,0.052154322456967585,0.052154322456967585,0.0,HIGH,1,kg
D833C77B7D7,efalizumab,EFALIZUMAB,0.0413,4.5204,atherosclerosis,0.0487,OTHER,,,,,,0.041331322672406454,0.041331322672406454,0.0,HIGH,1,kg
DC3E2F5C103,lifitegrast,LIFITEGRAST,0.0413,4.5204,atherosclerosis,0.0395,OTHER,,,,,,0.041331322672406454,0.041331322672406454,0.0,HIGH,1,kg
D076D1377B0,ccx354,CCX354,0.0222,1.0781,atherosclerosis,0.0268,OTHER,,,,,,0.02222339493443286,0.02222339493443286,0.0,HIGH,1,kg
DF60BD305CE,bms-817399,BMS-817399,0.0222,1.0781,atherosclerosis,0.0268,OTHER,,,,,,0.02222339493443286,0.02222339493443286,0.0,HIGH,1,kg
DA0BF76AF0B,azd4818,AZD4818,0.0222,1.0781,atherosclerosis,0.0268,OTHER,,,,,,0.02222339493443286,0.02222339493443286,0.0,HIGH,1,kg
D810E9E87EB,lomvastomig,LOMVASTOMIG,0.0218,0.562,atherosclerosis,0.0242,OTHER,,,,,,0.021813346529333106,0.021813346529333106,0.0,HIGH,1,kg
DE1D5BE3CB3,sabatolimab,SABATOLIMAB,0.0218,0.562,atherosclerosis,0.0242,OTHER,,,,,,0.021813346529333106,0.021813346529333106,0.0,HIGH,1,kg
DBF6A559B12,cobolimab,COBOLIMAB,0.0218,0.562,atherosclerosis,0.0242,OTHER,,,,,,0.021813346529333106,0.021813346529333106,0.0,HIGH,1,kg
DBA88A9E08D,alemtuzumab beta,ALEMTUZUMAB BETA,0.0205,0.5583,atherosclerosis,0.0205,OTHER,,,,,,0.005571,0.020456,0.014885,HIGH,2,kg
DCE512DA05F,alemtuzumab,ALEMTUZUMAB,0.0205,0.5583,atherosclerosis,0.0165,OTHER,,,,,,0.005571,0.020456,0.014885,HIGH,2,kg
DDFE1833BCE,rosiptor,ROSIPTOR,0.0035,4.8413,atherosclerosis,0.0035,OTHER,,,,,,0.0035317680106127123,0.0035317680106127123,0.0,HIGH,1,kg
D89B62CA048,colchicine,COLCHICINE,0.0,0.0,atherosclerosis,0.0,CV_EVENTS,,,,"COLCOT/LoDoCo2 — MACE reduction, FDA 2023",,0.0,0.0,0.0,LOW,0,literature
D3C7A2FBFE8,canakinumab,CANAKINUMAB,0.0,0.0,atherosclerosis,0.0,CV_EVENTS,,,,"CANTOS — anti-IL-1β, MACE reduction",,0.0,0.0,0.0,LOW,0,literature
D934F11095E,methotrexate,METHOTREXATE,0.0,0.0,atherosclerosis,0.0,CV_EVENTS,,,,"CIRT — anti-inflammatory, negative result",,0.0,0.0,0.0,LOW,0,literature
DEF03B860F1,losmapimod,LOSMAPIMOD,0.0,0.0,atherosclerosis,0.0,PLAQUE_IMAGING,,,,"p38 MAPK inhibitor, plaque imaging endpoints",,0.0,0.0,0.0,LOW,0,literature
D8E7425BC16,evolocumab,EVOLOCUMAB,0.0,0.0,atherosclerosis,0.0,CV_EVENTS,,,,"FOURIER — PCSK9 inhibitor, LDL + CV events",,0.0,0.0,0.0,LOW,0,literature
DFA19B07E43,tocilizumab,TOCILIZUMAB,0.0,0.0,atherosclerosis,0.0,CV_EVENTS,,,,"Anti-IL-6R, cardiovascular inflammation",,0.0,0.0,0.0,LOW,0,literature
